Regulatory News:
At 31 December 2023, resources made available for the liquidity
agreement concluded by Carmila (Paris:CARM) with Kepler Chevreux
were the following:
- 132,439 CARMILA shares; - Euro 889,996.
On 10 November 2023, the liquidity contract between BNP Paribas
Arbitrage and Carmila dated 28 June 2019 was terminated. On 3
November 2023, Carmila and Kepler Cheuvreux signed a liquidity
contract, which began on 13 November 2023.
During the 2nd half-year 2023, it has been negotiated a total
of:
- For purchase, 274,672 shares, for a total
amount of Euro 3,935,473 (1,898 transactions); - For sale, 244,989
shares, for a total amount of Euro 3,542,256 (1,774
transactions).
For information, at the time of the last assessments, available
resources were:
1. At the time of the previous half-yearly assessment at June
30, 2023, available resources were:
- 102,756 CARMILA shares; - Euro
1,279,923.
2. During the 1st half-year 2023, it has been negotiated a total
of:
- For purchase, 186,400 shares, for a total
amount of Euro 2,614,279 (1,226 transactions); - For sale, 189,670
shares, for a total amount of Euro 2,676,992 (1,222
transactions).
3. As of July 1st, 2021, date of implementation of the AMF
decision n°2021-01 dated June 22, 2021, the following resources
were:
- 112,910 CARMILA shares ; - Euro
991,074.
4. As of December 31, 2018, date of implementation of the AMF
decision n°2018-1 dated July 2, 2018, the following resources
were:
- 203,848 CARMILA shares; - Euro 743,970.
*withdrawal of 102,358 shares on July 1st, 2019.
INVESTOR AGENDA 13 February 2024 (after market
close): 2023 annual results 14 February 2024: Annual
results presentation 17 April 2024 (after market close):
Financial information for the first quarter 2024 24 April
2024: Annual Shareholder Meeting 24 July 2024 (after market
close): First half 2024 results 25 July 2024: First half
2024 results presentation 17 October 2024 (after market
close): Financial information for the third quarter 2024
ABOUT CARMILA
The third-largest listed owner of retail property in Europe,
Carmila was founded by Carrefour and institutional investors to
enhance the value of shopping centres adjoining Carrefour
hypermarkets in France, Spain and Italy. At 30 June 2023, its
portfolio was valued at €6.0 billion and made up of 202 shopping
centres, with leading positions in their catchment areas.
Carmila is listed on Euronext-Paris Compartment A under the
symbol CARM. It benefits from the tax regime for French real estate
investment trusts (“SIIC”).
Carmila has been a member of the SBF 120 since 20 June 2022.
Important notice
Some of the statements contained in this document are not
historical facts but rather statements of future expectations,
estimates and other forward-looking statements based on
management’s beliefs. These statements reflect such views and
assumptions prevailing as of the date of the statements and involve
known and unknown risks and uncertainties that could cause future
results, performance or events to differ materially from those
expressed or implied in such statements. Please refer to the most
recent Universal Registration Document filed in French by Carmila
with the Autorité des marchés financiers for additional information
in relation to such factors, risks and uncertainties. Carmila has
no intention and is under no obligation to update or review the
forward-looking statements referred to above. Consequently, Carmila
accepts no liability for any consequences arising from the use of
any of the above statements.
This press release is available in the
“Financial Press Releases” section of Carmila’s Finance webpage:
https://www.carmila.com/en/finance/financial-press-releases
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240116533088/en/
INVESTOR AND ANALYST CONTACT Jonathan Kirk – Head of Investor
Relations jonathan_kirk@carmila.com +33 6 31 71 83 98
PRESS CONTACT Elodie Arcayna – Corporate Communications Director
elodie_arcayna@carmila.com +33 7 86 54 40 10
Grafico Azioni Carisma Therapeutics (NASDAQ:CARM)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Carisma Therapeutics (NASDAQ:CARM)
Storico
Da Giu 2023 a Giu 2024